期刊文献+

复方玄驹胶囊联合二甲双胍、氯米芬治疗多囊卵巢综合征的效果及对氧化应激指标、HSP70、sFlt-1水平的影响 被引量:2

Effect of compound Xuanju capsule combined with metformin and clomiphene in the trentment of polycystic ovary syndrome and its influences on oxidative stress indexes,HSP70 and sFlt-1 levels
下载PDF
导出
摘要 目的分析复方玄驹胶囊联合二甲双胍、氯米芬治疗多囊卵巢综合征的效果。方法按照电脑盲选法将我院诊治的86例多囊卵巢综合征患者分为对照组(43例,二甲双胍+氯米芬)与研究组(43例,复方玄驹胶囊+二甲双胍+氯米芬)。比较两组的治疗效果。结果治疗3个月后,研究组的总抗氧化能力(TAC)、谷胱甘肽过氧化物酶(GPx)、超氧化物歧化酶(SOD)、可溶性血管内皮生长因子受体1(sFlt-1)、性激素结合球蛋白(SHBG)水平高于对照组,热休克蛋白70(HSP70)、血管内皮生长因子(VEGF)、血管紧张素Ⅱ(AngⅡ)、肝细胞生长因子(HGF)、硫酸脱氢表雄酮(DHEA-S)、抗缪勒管激素(AMH)水平低于对照组(P<0.05)。两组的不良反应总发生率无显著差异(P>0.05)。结论复方玄驹胶囊联合二甲双胍、氯米芬治疗多囊卵巢综合征的效果显著,能够改善患者的氧化应激反应、血管活性因子水平,调节HSP70、sFlt-1水平,临床可进一步推广应用。 Objective To analyze the effect of compound Xuanju capsule combined with metformin and clomiphene in the trentment of polycystic ovary syndrome.Methods A total of 86 patients with polycystic ovary syndrome who were treated in our hospital and were divided into control group(43 cases,metformin+clomiphene)and study group(43 cases,compound Xuanju capsule+metformin+clomiphene)according to the computer blind selection method.The therapeutic effects of the two groups were compared.Results After 3 months of treatment,the levels of total antioxidant capacity(TAC),glutathione peroxidase(GPx),superoxide dismutase(SOD),soluble fms-like tyrosine kinase-1(sFlT-1)and sex hormone-binding globulin(SHBG)in the study group were higher than those in the control group,and the levels of heat shock protein 70(HSP70),vascular endothelial growth factor(VEGF),angiotensinⅡ(AngⅡ),hepatocyte growth factor(HGF),dehydroepiandrosterone sulfate(DHEA-S)and anti-Müllerian hormone(AMH)were lower than those in the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Compound Xuanju capsule combined metformin and clomiphene in the treatment of polycystic ovary syndrome has a significant effect,which can improve the oxidative stress response and vasoactive factors levels of patients,and regulate the levels of HSP70 and sFlt-1.It can be further popularized and applied clinically.
作者 张丽杰 袁晓莉 ZHANG Lijie;YUAN Xiaoli(Xi'an Gaoxin Hospital,Xi'an 710075,China)
机构地区 西安高新医院
出处 《临床医学研究与实践》 2023年第18期119-122,共4页 Clinical Research and Practice
关键词 多囊卵巢综合征 复方玄驹胶囊 氧化应激指标 热休克蛋白70 polycystic ovary syndrome compound Xuanju capsule oxidative stress index heat shock protein 70
  • 相关文献

参考文献15

二级参考文献149

  • 1Yu-Hong Xia,Li Yao,Zhan-Xin Zhang.Correlation between IL-1β,IL-1Ra gene polymorphism and occurrence of polycystic ovary syndrome infertility[J].Asian Pacific Journal of Tropical Medicine,2013,6(3):232-236. 被引量:8
  • 2郁琦.多囊卵巢综合征诊治标准专家共识[J].中国实用妇科与产科杂志,2007,23(6):474-474. 被引量:107
  • 3李美芝,李蓉.多囊卵巢综合征诊断的金标准:鹿特丹标准?[J].中国实用妇科与产科杂志,2007,23(9):657-659. 被引量:153
  • 4ZawadsjuJK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach[M]. In: Dunaif A, GivenJR, Haseltine FP, eds. Polycystic ovary syndrome. Boston ( MA ) : Blackwell Scientific Publication, 1992,377-384.
  • 5Rotterdam ESHREI ASRM -Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS)[J]. Hum Reprod, 2004,19 :4147.
  • 6Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline[J].J Clin Endocrinol Metab, 2006, 91 :42374245.
  • 7Azziz R, Carmina E, Dewailly D, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of the Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009,91 :456488.
  • 8Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients[J].J Clin Endocrinol Metab, 2004,89:453462.
  • 9Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome[J]. Dermatol Ther, 2006,19:210-223.
  • 10Arias-Santiago S, Cutierrez-Salmeron MT, Castellote-Caballero L, et al. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study[J].JAm Acad Dermatol, 2010 ,63 :420- 429.

共引文献229

同被引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部